Literature DB >> 30256699

Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.

Jui-Hua Tsai1, Ann O Scheimann2, Shawn E McCandless3, Theresa V Strong4, John F P Bridges5.   

Abstract

OBJECTIVES: Prader-Willi syndrome (PWS) is a rare genetic disorder associated with varying degrees of hyperphagia, obesity, intellectual disability, and anxiety across the affected individuals' lifetimes. This study quantified caregiver priorities for potential treatment endpoints to identify unmet needs in PWS.
METHODS: The authors partnered with the International Consortium to Advance Clinical Trials for PWS (PWS-CTC) and a diverse stakeholder advisory board to develop a best-worst scaling instrument. Seven relevant endpoints were assessed using a balanced incomplete block design. Caregivers were asked to determine the most and least important of a sub-set of four endpoints in each task. Caregivers were recruited nationally though patient registries, email lists, and social media. Best-worst score was calculated to determine caregiver priorities; ranging from 0 (least important) to 10 (most important). A novel kernel-smoothing approach was used to analyze caregiver endpoint priority variations with relation to age of the PWS individual.
RESULTS: In total, 457 caregivers participated in the study. Respondents were mostly parents (97%), females (83%), and Caucasian (87%) who cared for a PWS individual ranging from 4-54 years. Caregivers value treatments addressing hyperphagia (score = 7.08, SE = 0.17) and anxiety (score = 6.35, SE = 0.16) as most important. Key variations in priorities were observed across age, including treatments targeting anxiety, temper outbursts, and intellectual functions.
CONCLUSIONS: This study demonstrates that caregivers prioritize hyperphagia and, using a novel method, demonstrates that this is independent of the age of the person with PWS. This is even the case for parents of young children who have yet to experience hyperphagia, indicating that these results are not subject to a hypothetical bias.

Entities:  

Keywords:  *C99; C89; Patients’ perspectives; Prader-Willi Syndrome; best–worst scaling; endpoint prioritization; hyperphagia; patients’ preferences; rare disease

Mesh:

Year:  2018        PMID: 30256699     DOI: 10.1080/13696998.2018.1528980

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  6 in total

1.  Associations Between Hyperphagia, Symptoms of Sleep Breathing Disorder, Behaviour Difficulties and Caregiver Well-Being in Prader-Willi Syndrome: A Preliminary Study.

Authors:  Jessica Mackay; Gillian M Nixon; Antony R Lafferty; Geoff Ambler; Nitin Kapur; Philip B Bergman; Cara Schofield; Chris Seton; Andrew Tai; Elaine Tham; Komal Vora; Patricia Crock; Charles Verge; Yassmin Musthaffa; Greg Blecher; Daan Caudri; Helen Leonard; Peter Jacoby; Andrew Wilson; Catherine S Choong; Jenny Downs
Journal:  J Autism Dev Disord       Date:  2021-09-08

2.  Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.

Authors:  Nathalie Kayadjanian; Caroline Vrana-Diaz; Jessica Bohonowych; Theresa V Strong; Josée Morin; Diane Potvin; Lauren Schwartz
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

3.  Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review.

Authors:  Ilene L Hollin; Jonathan Paskett; Anne L R Schuster; Norah L Crossnohere; John F P Bridges
Journal:  Pharmacoeconomics       Date:  2022-07-15       Impact factor: 4.558

Review 4.  Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium.

Authors:  Lauren Schwartz; Assumpta Caixàs; Anastasia Dimitropoulos; Elisabeth Dykens; Jessica Duis; Stewart Einfeld; Louise Gallagher; Anthony Holland; Lauren Rice; Elizabeth Roof; Parisa Salehi; Theresa Strong; Bonnie Taylor; Kate Woodcock
Journal:  J Neurodev Disord       Date:  2021-06-21       Impact factor: 4.025

5.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

6.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.